Name: Cryo-Cell International, Inc. (CCEL) Financial Statements
Creator: FinSpry

Cryo-Cell International Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Cryo-Cell International, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 2024	Nov 2023	Nov 2022	Nov 2021	Nov 2020	Nov 2019	Nov 2018
Revenue & Gross Profit
Revenue	31.99	31.34	30.34	28.88	31.15	31.82	29.22
Cost of Revenue	7.95	8.39	8.79	-8.99	10.94	-10.04	8.54
Gross Profit	24.04	22.95	21.54	19.90	20.21	-10.04	20.68
Operating Expenses
Research & Development	1.24	1.17	0.38	0.05	0.02	0.03	0.09
Selling, General & Administrative	18.52	17.17	15.58	14.63	14.29	14.89	15.63
Operating Expenses	20.56	19.46	17.08	15.51	14.48	15.13	15.90
Operating Income	3.48	-12.30	4.46	-24.50	5.72	-25.16	4.77
Other Income/Expense
Interest Income	0.00	0.12	0.00	0.00	0.00	0.00	0.00
Interest Expense	1.86	-1.24	-1.08	-1.38	-1.54	0.00	1.55
Other Income/Expense	-0.68	15.62	0.00	-28.49	0.00	-30.26	0.39
Income
Income Before Tax	2.80	-13.36	3.32	2.61	5.04	3.39	3.62
Income Tax Expense	2.40	-3.84	0.55	0.53	1.41	1.10	4.47
Net Income	0.40	-9.52	2.77	2.08	3.62	2.29	-0.85
Net Income - Continuous Operations	0.40	-9.52	2.77	2.08	0.00	0.00	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBITDA	1.42	-10.73	5.96	5.32	6.09	5.61	5.48
EBIT	4.67	-12.13	4.46	3.99	5.72	5.09	5.16
Depreciation & Amortization	0.48	1.12	1.50	0.83	0.37	0.21	0.18
Earnings Per Share
Basic EPS	-	-1.00	-	-	-	-	-
Diluted EPS	-	-1.00	-	-	-	-	-
Basic Shares Outstanding	8.13	8.34	8.47	8.14	7.54	7.79	7.46
Diluted Shares Outstanding	8.21	8.34	8.48	8.36	8.14	8.41	7.46